Business Wire

SOSAFE

29.5.2024 13:13:30 CEST | Business Wire | Press release

Share
SoSafe Announces New Executive Advisors as Company Expands Category and Product Leadership

SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed four new Executive Advisors. The advisors, comprised of industry experts and technology investors, will provide advice and strategic counsel to the SoSafe leadership team on its ambitious plans to expand their category and product leadership.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240529386435/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

New hires Ilona Simpson, Carsten Thoma, Christian Karam, Sean Catlett (Photo: Business Wire)

With Forrester predicting that 90% of data breaches in 2024 will involve the human element, reducing human risk is what organisations need to prioritize for business continuity. SoSafe offers a technology-driven solution based on psychology and human-centric design. While SoSafe is committed to empowering digital self-defence around the world, the company is currently leading the category evolution from security awareness and training to human risk management. The Executive Advisors will support this transformative process from both an industry and organisational perspective to increase the company's speed to scale.

The following Executive Advisors will join:

Sean Catlett: Sean is the Chief Information Security and Trust Officer at Bumble. He also served as the Chief Security Officer at Slack, and as Chief Information Security Officer at Reddit and is an advisor to Balance Theory and Hampton North.

"It is clear that cybercriminals are effective at focusing on the human layer of security. AI-powered tools offer them solutions that scale attack success rates, intensifying cyber threats, and I believe the full potential is yet to be seen. We need comprehensive and effective solutions that counter these rising threats by sustainably empowering a strong security culture and reducing human risk - and SoSafe delivers just that in a new and innovative way", states Sean Catlett.

Christian Karam: Christian is an investor and senior advisor on technology investments, previously serving as the Deputy Group Chief Information Security Officer at UBS and the Head of Research & Innovation at INTERPOL.

“Cybercriminals continue to innovate rapidly, outpacing many organisations’ ability to keep up. Mere compliance training videos are no longer enough to overcome this challenge. We must rethink security awareness by building effective and robust security cultures that embrace continuous learning and treat mistakes as key drivers of resilience. SoSafe is leading this transformation towards holistic, people-centric human risk management, and I look forward to contributing to this journey”, says Christian Karam.

Ilona Simpson: Ilona is a trained psychologist and a long-standing CIO across a range of industries and companies, having worked at Netskope, adidas, EON, Aston Martin, DHL, and Porsche.

"We've made a lot of progress over the last few years in terms of the attention that senior management and boards are giving to the human layer of cybersecurity. For CIOs, the human factor and reducing human risk is top of mind. Now, they need effective and simple solutions to help them reduce human risk in a sustainable way”, states Ilona Simpson.

Carsten Thoma: Carsten is the President of Celonis. He has co-founded and scaled Hybris, sold to SAP and became President of SAP CX and member of the Global Executive Team. He serves as an advisor to La Famiglia/General Catalyst, and has been a long-standing investor and entrepreneur.

"SoSafe has the most promising foundation a young company can have: They are solving one of the most important business problems of our time in a fundamentally different way than their competitors. It's my ambition to help them succeed and, together with SoSafe's leadership team, build a global champion from Europe”, states Carsten Thoma.

“We are very honoured that some of the best minds in business and technology have agreed to serve as critical advisors to SoSafe. At this pivotal time in our development, their expertise will enable us to grow even faster, smarter, and more focused. I know I speak for the rest of the executive team when I say that we will value their experienced counsel as we look to accelerate our growth as a company”, states Dr Niklas Hellemann, Psychologist and CEO at SoSafe.

About SoSafe

SoSafe, founded by a team of behavioural scientists and technology experts, is the largest security awareness and human risk management vendor based in Europe. SoSafe is empowering over 4700 customers worldwide to effectively mitigate cyber risk. With a unique human-centric approach grounded in behavioural science, SoSafe enhances secure behaviour across organizations, making it intuitive and second nature. The platform is designed to strengthen digital self-defence by creating robust security cultures that actively involve employees in mitigating human risks. By leveraging psychology and advanced technology and AI, it enables security professionals to effectively identify, prioritize, manage, and ultimately reduce their human risk. The SoSafe team now consists of more than 450 employees in seven locations: Cologne (headquarters), Amsterdam, Berlin, London, Paris, Lisbon, and Munich.

Website: www.sosafe-awareness.com/
LinkedIn: www.linkedin.com/company/sosafe-cyber-security/mycompany/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529386435/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye